Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea
None Vivos Therapeutics has received 510(k) clearance for the use of its oral devices in adults with severe obstructive sleep apnea (OSA). • None The Food and Drug Administration ruling, which comes 11 months after Vivos received clearance for an oral appliance in mild-to-moderate OSA, gives the…#nonevivos #osa #vivos #fda #philips #kirkhuntsman #medicare #medtechdive
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Food and Drug Administration (FDA) | Health | Medicare | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine